Google continues to invest in health start-ups

By Catherine Sturman
Digital technology is continually transforming traditional industries, and health care is no exception. In the last five years, tech giants have increas...

Digital technology is continually transforming traditional industries, and health care is no exception. In the last five years, tech giants have increasingly looked at healthcare as a potential growth market, merging technology, data and healthcare in order to develop new products and services to support its users obtain a higher quality of living anywhere in the world.

In 2015, Google launched its DeepMind Health initiative, signifying its interest in supporting the medical profession through AI and machine learning capabilities in order to support the delivery of exceptional health care, either at home or within an acute setting.

With this in mind, the company’s recent acquisition of Seattle-based start-up Senosis Health is of no surprise. Originally reported by GeekWire, the technology has been created by US Professor and entrepreneur Shwetak Patel, alongside a large number of clinicians, researchers and tech experts. The technology has enabled the ability for users to turn mobile technologies into medical diagnosis tools. Financial details surrounding the acquisition have not been disclosed.

Related stories

Through the use of inbuilt sensors, smartphones are able to become useful medical assets in the tracking of essential health statistics, monitoring ongoing conditions.

In an early interview with GeekWire, Patel commented: “The sensors that are already on the mobile phone can be repurposed in interesting new ways, where you can actually use those for diagnosing certain kinds of diseases.” Its apps help provide data on areas such as a user’s haemoglobin levels through the HemaApp, alongside the company’s SpiroSmart app, which measures a user’s lung function through the phone’s microphone.

Through the acquisition, Senosis Health will remain as part of Google’s parent company, Alphabet, but will not become part of Google’s research organisation, Verily Life Sciences, but remain separate, signifying Google’s desire to keep the two as separate areas of development.


Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability